OmniAb, Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About OmniAb, Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
/ 
Frequently asked questions
To buy OmniAb, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for OmniAb, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for OmniAb, Inc. is OABI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
OmniAb, Inc. has its primary listing on NASDAQ. You can trade OmniAb, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, OmniAb, Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include OmniAb, Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like OmniAb, Inc..